Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Indian Journal of Cancer
S GhoshC N Nair
Outcome of children treated for relapsed acute myeloid leukemia in Central America
(opens in new tab)Pediatric Blood & Cancer
Stacey MarjerrisonLillian Sung
The Journal of Reproductive Medicine
Marianna AlperinMark D Hornstein
American Journal of Clinical Pathology
R H EdwardsK E Salhany
Revista da Associação Médica Brasileira
Flávia Leite Souza SantosE M Rego